Novo Not Discussing Further Pill Discounts, CEO Says

Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. "We are not right now discussing further discounts," Doustdar tells…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.